Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Plasma proteomics reveals divergent sex-specific senescence and bone biology signatures across neurodegenerative diseases.

bioRxiv : the preprint server for biology·2026
Same author

Transcription-independent induction of rapid-onset senescence is integral to healing.

Nature cell biology·2026
Same author

MicroRNA networks associated with skeletal aging and WNT pathway modulation.

Calcified tissue international·2026
Same author

Forearm BMD predicts fracture independently of FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Impact of Mild Autonomous Cortisol Secretion on Bone Density, Metabolism, and Microstructure: A Cross-sectional Study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Correction: Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
查看所有相关文章

相关实验视频

Updated: Jun 27, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

23.9K

一个用于老化药物的管道.

Sundeep Khosla

    The Journal of clinical investigation
    |May 1, 2024
    PubMed
    概括
    此摘要是机器生成的。

    研究人员开发了一种新方法来寻找可以杀死衰老细胞的老化药物. 这种使用体内诱导衰老的方法将XL888确定为异常性肺纤维化症的潜在治疗方法.

    更多相关视频

    Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
    10:33

    Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

    Published on: July 23, 2016

    10.5K
    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
    14:20

    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

    Published on: June 13, 2014

    16.7K

    相关实验视频

    Last Updated: Jun 27, 2025

    SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
    07:39

    SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

    Published on: June 28, 2019

    23.9K
    Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
    10:33

    Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

    Published on: July 23, 2016

    10.5K
    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
    14:20

    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

    Published on: June 13, 2014

    16.7K

    科学领域:

    • 细胞衰老 细胞衰老
    • 药物发现 药物发现
    • 与年龄有关的疾病与年龄有关的疾病.

    背景情况:

    • 衰老细胞有助于与年龄相关的疾病.
    • 目前的老化药物查使用体外诱导的衰老,这可能不会反映体内条件.
    • 开发针对体内衰老细胞的老化药物至关重要.

    研究的目的:

    • 建立一种高通量药物查管道,用于使用体内诱导衰老的老化化合物.
    • 为了识别针对特定的活体衰老细胞群体有效的新型老化化合物.
    • 评估候选老化药物用于治疗与年龄相关的疾病,如异常性肺纤维化.

    主要方法:

    • 开发一个高吞吐量选管道的 senolytic 化合物.
    • 在体内诱导衰老.
    • 使用开发的管道对化合物的选.
    • 鉴定HSP90抑制剂XL888作为候选老化剂.

    主要成果:

    • 建立了一条新的管道,用于对老化药物的高通量选.
    • 在体内成功诱导衰老.
    • HSP90抑制剂XL888被确定为一个有前途的老化剂候选者.
    • XL888显示出治疗异常性肺纤维化的潜力.

    结论:

    • 开发的体内衰老查管道为识别老化剂提供了更相关的方法.
    • XL888是一种潜在的老化药物,用于治疗异常性肺纤维化.
    • 这项研究为发现针对各种与年龄有关的疾病的向老化药物铺平了道路.